Upper GI 2017

Recent advancements in genomic technology have now allowed GCs to be studied at high resolution and at the molecular level Such molecular profiling data have greatly facilitated identification of candidate driver alterations in GC Achieving an understanding of potential driver alterations involved in GC pathogenesis can lead to the identification of clinically important biomarkers and potential treatment targets

03/28/2017